pISSN 1226-6051
eISSN 2508-786X

Table. 2.

Table. 2.

Meta analyses of clinical characteristics

Study Sample size (N) N (%)

Fever Cough Fatigue/myalgia Dyspnea/tachypnea Asymptomatic
Lu X, et al.3 171 71 (41.5) 83 (48.5) 13 (7.6) N/R 27 (15.8)
Su L, et al.11 9 2 (22.2) 1 (11.1) N/R N/R 6 (66.7)
Zhou Y, et al.12 9 4 (44.4) 2 (22.2) N/R N/R 5 (55.6)
Wei M, et al.13 9 4 (44.4) 2 (22.2) N/R N/R 1 (11.1)
Li W, et al.14 5 1 (20.0) 1 (20.0) N/R N/R 4 (80.0)
Zheng F, et al.15 25 13 (52.0) 11 (44.0) N/R 2 (8.0) N/R
Cai J, et al.16 10 8 (80.0) 6 (60.0) N/R 0 N/R
Liu H, et al.17 4 3 (75.0) 3 (75.0) 1 (25.0) N/R 0
Liu W, et al.18 6 6 (100.0) 6 (100.0) N/R 1 (16.7) 0
Qiu H, et al.19 36 13 (36.1) 7 (19.4) N/R 1 (2.8) 10 (27.8)
Wang D, et al.20 31 20 (64.5) 14 (45.2) 3 (9.7) N/R 4 (12.9)
Liu M, et al.21 5 2 (40.0) 2 (40.0) N/R N/R 3 (60.0)
Meta-analyses outcomes (random-effects model)
Patients with positive outcome/included patients (n) 147/320 138/320 17/206 4/77 60/285
Proportion (%) 48.2 39.3 8.4 6.9 30.4
95% CI 38.4-58.1 28.9-50.7 5.3-13.2 2.7-16.2 17.5-47.4
I2 statistics 41 51 0 0 69
τ2 0.16 0.26 0 0 0.75
P-value 0.07 0.02 0.48 0.61 <0.01
P-value of Egger’s test 0.2847 0.4173 0.1758 0.8337 0.1957

CI, confidence interval; N/R, not reported

Korean J Clin Pharm 2020;30:270-8 https://doi.org/10.24304/kjcp.2020.30.4.270
© 2020 Korean J Clin Pharm